From: Predictors of arthritis in pediatric patients with lupus
No Arthritis during follow-up | Arthritis present during follow-up | P-value | |
---|---|---|---|
N = 25 | N = 22 | ||
Age, years (SD) | 12.5 (3.5) | 11.8 (4.2) | 0.6 |
Gender, n (%) F | 22 (88) | 20 (90) | 0.9 |
Race, % AA | 17 (68) | 14 (64) | 0.3 |
ANA, n (%) positive | 25 (100) | 22 (100) | - |
dsDNA, n (%) positive | 21 (84) | 15 (68) | 0.4 |
Ro, n (%) positive | 7/18 (39) | 1/6 (16) | 0.4 |
La, n (%) positive | 5/18 (28) | 0/6 (0) | 0.1 |
RNP, n (%) positive | 9/20 (45) | 5/9 (55) | 0.5 |
Sm, n (%) positive | 11/20 (55) | 4/8 (50) | 0.4 |
Low C3, n (%) | 21 (84) | 13 (59) | 0.8 |
Low C4, n (%) | 15 (60) | 13 (59) | 0.8 |
Elevated CRP, n (%) | 13 (52) | 2 (9) | 0.02 |
Elevated ESR, n (%) | 18 (72) | 13 (59) | 0.4 |
Renal disorder, n (%) | 16 (64) | 9 (41) | 0.8 |
Hematologic disorder, n (%) | 11 (44) | 4 (18) | 0.2 |
Fever, n (%) | 4 (16) | 4 (18) | 0.4 |
Malar rash, n (%) | 4 (16) | 11 (50) | 0.02 |
Mucosal ulcerations, n (%) | 2 (8) | 2 (9) | 0.6 |
Alopecia, n (%) | 22 (88) | 2 (9) | 0.007 |
Mean SLEDAI | 12.8 ± 14.2 | 10.7 ± 11.7 | 0.6 |
Mean SLAM | 5.1 ± 3.6 | 5.4 ± 3.1 | 0.6 |